Fig. 1 · Structure
Documents & Downloads
Ro 22-9194
Anti-arrhythmias Drug
Ro 22-9194 is an anti-arrhythmic agent that inhibits thromboxane A2 (TXA2) synthetase activity, affecting platelet aggregation in both rabbit and human models. This compound demonstrates significant efficacy in suppressing various types of model arrhythmias. Additionally, Ro 22-9194 possesses non-cholinergic cardiac depressant properties, complemented by its vasodilatory effects, making it valuable for cardiovascular research applications.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 106134-33-2 |
| Applications | Anti-arrhythmias Drug |
| Formula | C19H27Cl2N3O |
| Molecular Weight | 384.34 |
| SMILES | CC(N)C(N(C1=C(C)C=CC=C1C)CCCC2=CC=CN=C2)=O.[H]Cl.[H]Cl |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.